The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases
MedComm · 2025-06 · 6 (6)
DOI: 10.1002/mco2.70213 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 06.06.2025. Verfasst von Yi Qiu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Industrial Institute of Antibiotics School of Pharmacy Chengdu University Chengdu China. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 430 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chengdu University, National Natural Science Foundation of China.
Abstract (Originalsprache)
The blood–brain barrier (BBB) is a highly selective and protective barrier that restricts the entry of most therapeutic agents into the central nervous system (CNS), posing a significant challenge for the treatment of CNS diseases. The nose‐to‐brain drug delivery (NBDD) route has emerged as a promising strategy to bypass the BBB, offering direct, noninvasive, and efficient transport of drugs to the brain. This review begins with a concise overview of the BBB structure and its biofunctions, followed by an in‐depth discussion of the mechanisms underlying the nose‐to‐brain pathway, including the olfactory and trigeminal nerve routes, and respiratory pathway. We further highlight the therapeutic research development of neurodegenerative diseases, acute neurological diseases, brain tumor, and psychiatric disorders when using NBDD drugs encompassing small‐molecule drugs, proteins, peptides, nucleic acids, siRNA, and herbal compounds, in which we also introduce innovative delivery systems, including nanocarriers and novel platforms such as exosomes, which enhance drug stability, targeting efficiency, and bioavailability. In addition, we provide a comprehensive overview of recent clinical advancements in therapeutics delivered via the intranasal route for CNS diseases. Finally, we discuss the challenges and future directions of NBDD, emphasizing its potential to transform the treatment landscape for CNS disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sichuan Industrial Institute of Antibiotics School of Pharmacy Chengdu University Chengdu China.
- Department of Endocrinology and Metabolism Shanghai Pudong Gongli Hospital Pudong New Area Shanghai China.
- Department of Technology Sichuan Youngster Technology Co., Ltd Chengdu China.
- Jiangxi University of Traditional Chinese Medicine Nanchang China.
- Department of Geriatrics Geriatric Diseases Institute of Chengdu Chengdu Fifth People's Hospital Chengdu China.
Förderung
- Chengdu University
- National Natural Science Foundation of China
Zitieren
APA
Qiu, Y., Huang, S., Peng, L., Yang, L., Zhang, G., Liu, T., Yan, F., & Peng, X. (2025). The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases. MedComm, 6(6). https://doi.org/10.1002/mco2.70213
Vancouver
Qiu Y, Huang S, Peng L, Yang L, Zhang G, Liu T, et al. The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases. MedComm. 2025;6(6). doi:10.1002/mco2.70213
BibTeX
@article{Qiu2025,
author = {Qiu, Yi and Huang, Shiyuan and Peng, Li and Yang, Li and Zhang, Guosong and Liu, Tao and Yan, Fang and Peng, Xi},
title = {The Nasal–Brain Drug Delivery Route: Mechanisms and Applications to Central Nervous System Diseases},
journal = {MedComm},
year = {2025},
volume = {6},
number = {6},
doi = {10.1002/mco2.70213}
}
EUVIMED